Skip to main content

Life Sciences is now live. See how →

Patent Examiner Matthew D. Krcha

Art Unit 1796 · Lab Apparatus, Microfluidics, Bioreactors & Analytical Testing · Tech Center 1700 · 205 applications filed 2021–2026

⚑ Hard · harder than 80% of examiners● Free examiner data

Matthew D. Krcha is a USPTO patent examiner in Art Unit 1796 (Lab Apparatus, Microfluidics, Bioreactors & Analytical Testing) with 205 applications from filing years 2021–2026. Examiner Krcha's allowance rate is 63.5%, below the 82.2% USPTO average for applications filed in the same years. The examiner ranks harder than 80% of examiners. In 2021, decided applications with an examiner interview were allowed 34.0 percentage points more often than those without.

Data through November 2026 from USPTO Patent Center (formerly PAIR) · Methodology

Overview

Free
Difficulty · Hard
harder than 80% of examiners
Easier80th percentileHarder
Allowance rate vs peers
Examiner Krcha63.5%
Art Unit 179672.4%
USPTO average82.2%
Allowance rate
63.5%
▼ USPTO avg 82.2%
Applications
205
filing years 2021–2026
First-action allowance
15.3%
patented with no rejection
Abandoned
15.1%
share of applications
Avg office actions
1.6
USPTO avg 1.3
Days to first OA
980
▲ USPTO 632
RCE rate
30.2%
USPTO 20.4%
Interview rate
24.9%
USPTO 28.0%

Examiner details

  • Art unit1796 · Lab Apparatus, Microfluidics, Bioreactors & Analytical Testing
  • Title / gradePrimary Patent Examiner · GS-14
  • Service12 years
  • PhoneOn each office action
  • Email[email protected]
  • In USPTO recordsKRCHA, MATTHEW D
Full signatory authority

Examiner Krcha can allow an application without a supervisory sign-off.

Examines (USPC classes)
422 · Chemical Apparatus & Process Disinfecting, Deodorizing, Preserving, or Sterilizing435 · Chemistry: Molecular Biology & Microbiology436 · Analytical & Immunological Testing

How to improve your odds with Examiner Krcha

  • The data favors an interview. Interviewed cases were allowed more often in both measured years, by 28.9 to 34.0 points.
  • Plan for the timeline. First office action averages 980 days vs the 632-day USPTO norm.
  • Expect a §103. Obviousness is the most-issued rejection (130), and applicants overcame it 33.8% of the time.
  • The data favors an RCE here. Cases with an RCE were allowed more often in both measured years, by 37.1 to 38.0 points.

Historical patterns from this examiner's past cases, shown for general information. This is not legal advice and does not predict the outcome of any specific application. Decisions about interviews, RCEs, and claim strategy should be made with a licensed patent attorney or agent.

Rejection patterns & how they get overcome

Free
§102 Novelty72 issued · 45.2% overcome
§103 Obviousness130 issued · 33.8% overcome
§112 Definiteness & disclosure52 issued · 50.0% overcome
How applicants traverse §103 rejections🔒 Members

Applicants overcame 24 of the 71 decided §103 obviousness rejections from Examiner Krcha in the data. Each winning response, with its arguments and claim amendments, is in the file wrapper.

Read the winning §103 argumentsFull REMARKS, amendments, claim trees & redlines from the file wrappers
Start free

Just got an office action from Examiner Krcha?

Draft your response with Examiner Krcha's record and Art Unit 1796's history in view, including the rejection patterns, the interview record, and the arguments that have overcome them. See office action responses in AI Studio.

Open AI Studio free →

RCE behavior

Allowance after a Request for Continued Examination versus without one, per year. Use it to judge whether an RCE is worth the cost in front of Examiner Krcha.

YearRCE rateAllowance w/ RCEAllowance w/oDelta
202247.4%90.9%53.8%+37.1pp
202141.4%81.8%43.8%+38.0pp

Recent outcomes

Free🔒 Case detail for members
App #TitleOutcomeOAsArguments & redline
19/684665Control Systems and Methods for Exhaust Pollution MitigationPatented0🔒 View
17/224337Device and Method for Isolating a Target from a Biological SamplePatented3🔒 View
18/482724Unsupervised Techniques for Identifying Univariate and Multivariate Anomalies in Scientific Instrument Results Within a Laboratory Information Management SystemPatented0🔒 View
17/936200Flow Cells with Dark QuencherPatented3🔒 View
See all 205 applications with full file-wrapper detailOffice action text, attorney arguments, amendments & claim-by-claim track changes
Start free

Art Unit 1796 technology

Analyzers & sample handlingChemical & biochemical analysisMicrofluidic devicesBioreactors & cell culture apparatusTop CPC B01L · G01N · C12M
About this examiner. Matthew D. Krcha examines in Art Unit 1796 (Lab Apparatus, Microfluidics, Bioreactors & Analytical Testing, Tech Center 1700).

Frequently asked questions

What is Examiner Matthew D. Krcha's allowance rate?
Examiner Krcha's allowance rate is 63.5%, compared with 82.2% across the USPTO and 72.4% in Art Unit 1796 for applications filed in the same years. That rate ranks Examiner Krcha harder than 80% of examiners.
Is Examiner Krcha a hard examiner?
Somewhat. Examiner Krcha ranks harder than 80% of examiners, in the 80th difficulty percentile (hard). Examiner Krcha has a 63.5% allowance rate versus 82.2% across the USPTO and 72.4% in Art Unit 1796, 1.6 office actions per application versus 1.3, and an RCE rate of 30.2% versus 20.4% across the USPTO, for applications filed in the same years.
Do examiner interviews help with Examiner Krcha?
In this examiner's record, yes. Decided applications with an interview were allowed more often in both measured years, by 28.9 to 34.0 percentage points. In 2021, 76.9% of decided applications with an interview were allowed, versus 42.9% of those without.
What is Examiner Krcha's most common rejection?
§103 obviousness, issued 130 times in the data. Applicants overcame it 33.8% of the time.
Is an RCE worth filing with Examiner Krcha?
In this examiner's record, yes. Decided applications with an RCE were allowed more often in both measured years, by 37.1 to 38.0 percentage points. In 2022, 90.9% of decided applications with an RCE were allowed, versus 53.8% of those without one.
How long until the first office action from Examiner Krcha?
About 980 days on average, versus 632 days across the USPTO for applications filed in the same years.
How do I contact Examiner Matthew D. Krcha?
Examiner Krcha can be reached by email at [email protected]. The examiner's direct line is listed at the end of the examiner's office actions.

Put Examiner Krcha's data to work on your next response.

Full file-wrapper detail, winning arguments, and AI-assisted drafting in one workspace.

Start free
Statistics are computed by Boundly Prosecution Intel from USPTO Patent Center (formerly PAIR) file wrappers for filing years 2021–2026, refreshed regularly. Allowance rate (sometimes called grant rate) is the share of disposed applications that issued as patents. Office actions here are non-final and final rejections, so restriction requirements and allowances are not counted. USPTO benchmarks are weighted to each examiner's mix of filing years, and art-unit benchmarks to the art units and filing years of the examiner's own applications, so they compare like for like. The difficulty percentile ranks examiners, each counted once, so it can point the other way from the USPTO average, which counts applications. See how each number is computed. The year-by-year interview and RCE tables show up to four recent filing years, leaving out the newest one and any year with fewer than ten applications or five decided applications on either side. Historical data is provided for informational purposes only. Past examiner behavior does not guarantee future outcomes, and nothing here is legal advice or a substitute for advice from a licensed patent attorney or agent. Are you Matthew D. Krcha, or see an error? Request a correction.